BRIACELL THERAPEUTICS CORP. Operating Loss Carryforwards
BRIACELL THERAPEUTICS CORP. (BCTX) had Operating Loss Carryforwards of $26.41 million as of 2024-07-31, per its 10-K filed 2024-10-29.
Financial Statements › Notes › Income Taxes
us-gaap:OperatingLossCarryforwards · last filed 2024-10-29
- 2024-07-31: Operating Loss Carryforwards $26.41M.
- 2023-07-31: Operating Loss Carryforwards $23.34M.
- 2022-07-31: Operating Loss Carryforwards $18.89M.
| Period end | Operating Loss Carryforwards |
|---|---|
| 2024-07-31 | $26.41M 10-K · filed 2024-10-29 |
| 2023-07-31 | $23.34M 10-K · filed 2023-10-25 |
| 2022-07-31 | $18.89M 10-K · filed 2022-10-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |